Impact of Microalbuminuria on Incident Stroke A Meta-Analysis

被引:82
作者
Lee, Meng [1 ,2 ,3 ]
Saver, Jeffrey L. [1 ,2 ]
Chang, Kuo-Hsuan
Liao, Hung-Wei
Chang, Shen-Chih [4 ]
Ovbiagele, Bruce [1 ,2 ]
机构
[1] Univ Calif Los Angeles, Stroke Ctr, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA
[3] Chang Gung Mem Hosp, Dept Neurol, Chiayi, Taiwan
[4] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA
基金
美国国家卫生研究院;
关键词
endothelial dysfunction; incidence; meta-analysis; microalbuminuria; stroke; TYPE-2; DIABETES-MELLITUS; CARDIOVASCULAR EVENTS; COST-EFFECTIVENESS; METABOLIC SYNDROME; RISK-FACTORS; ALBUMINURIA; PROTEINURIA; REDUCTION; MORTALITY; DISEASE;
D O I
10.1161/STROKEAHA.110.581215
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Microalbuminuria, a marker of both kidney disease and endothelial dysfunction, may be associated with global vascular risk, but the nature and magnitude of the link between microalbuminuria and incident stroke has not been clearly defined. The purpose of this study was to assess the consistency and strength of the association of microalbuminuria with risk of stroke in prospective studies using meta-analysis. Methods-We conducted a systematic search of electronic databases and bibliographies for studies reporting a multivariate-adjusted estimate, represented as relative risk with 95% CI, of the association between microalbuminuria and stroke risk. Studies were excluded if a majority of study participants had established kidney disease or pre-eclampsia. Estimates were combined using a random-effect model. Results-We identified 12 studies, with a total of 48 596 participants and 1263 stroke events. Overall, presence of microalbuminuria was associated with greater stroke risk (relative risk, 1.92; 95% CI, 1.61 to 2.28; P<0.001) after adjustment for established cardiovascular risk factors. There was evidence of significant heterogeneity in the magnitude of the association across studies (P for heterogeneity <0.001, I-2=68%), which was partially explained by differences in study population, microalbuminuria definition, and different microalbuminuria-related risk among stroke subtypes. However, in stratified analyses, microalbuminuria was associated with increased risk of subsequent stroke in all subgroups (general population, diabetics, those with known stroke). Conclusions-Microalbuminuria is strongly and independently associated with incident stroke risk. Future studies should explore whether microalbuminuria is just a risk marker or a modifiable risk factor for stroke. (Stroke. 2010;41:2625-2631.)
引用
收藏
页码:2625 / 2631
页数:7
相关论文
共 37 条
[1]   Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria [J].
Asselbergs, FW ;
Diercks, GFH ;
Hillege, HL ;
van Boven, AJ ;
Janssen, WMT ;
Voors, AA ;
de Zeeuw, D ;
de Jong, PE ;
van Veldhuisen, DJ ;
van Gilst, WH .
CIRCULATION, 2004, 110 (18) :2809-2816
[2]   Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of REnal and vascular ENdstage disease (PREVEND) study and the prevention of REnal and vascular ENdstage disease intervention trial (PREVEND IT) [J].
Atthobari, J ;
Asselbergs, FW ;
Boersma, C ;
de Vries, R ;
Hillege, HL ;
van Gilst, WH ;
Gansevoort, RT ;
de Jong, PE ;
de Jong-van den Berg, LTW ;
Postma, MJ .
CLINICAL THERAPEUTICS, 2006, 28 (03) :432-444
[3]   Microalbuminuria in ischemic stroke [J].
Beamer, NB ;
Coull, BM ;
Clark, WM ;
Wynn, M .
ARCHIVES OF NEUROLOGY, 1999, 56 (06) :699-702
[4]   Framingham Stroke Risk Function in a Large Population-Based Cohort of Elderly People The 3C Study [J].
Bineau, Sebastien ;
Dufouil, Carole ;
Helmer, Catherine ;
Ritchie, Karen ;
Empana, Jean-Philippe ;
Ducimetiere, Pierre ;
Alperovitch, Annick ;
Bousser, Marie Germaine ;
Tzourio, Christophe .
STROKE, 2009, 40 (05) :1564-1570
[5]   Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy - Implications for decision making [J].
Boersma, Cornelis ;
Atthobari, Jarir ;
Gansevoort, Ron T. ;
de Jong-Van den Berg, Lolkje T. W. ;
de Jong, Paul E. ;
de Zeeuw, Dick ;
Annemans, Lieven J. P. ;
Postma, Maarten J. .
PHARMACOECONOMICS, 2006, 24 (06) :523-535
[6]   Screening for proteinuria in US adults - A cost-effectiveness analysis [J].
Boulware, LE ;
Jaar, BG ;
Tarver-Carr, ME ;
Brancati, FL ;
Powe, NR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (23) :3101-3114
[7]   Risk factors for stroke in type 2 diabetes mellitus - United Kingdom prospective diabetes study (UKPDS) 29 [J].
Davis, TME ;
Millns, H ;
Stratton, IM ;
Holman, RR ;
Turner, RC .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) :1097-1103
[8]   Microalbuminuria as an early marker for cardiovascular disease [J].
de Zeeuw, Dick ;
Parving, Hans-Henrik ;
Henning, Robert H. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (08) :2100-2105
[9]  
Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619
[10]   Cost-effectiveness of screening for proteinuria [J].
Gansevoort, RT ;
de Jong, PE ;
Postma, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (12) :1442-1443